Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
DeLong Mark Jeffrey disposed of 149,937 Apellis Pharmaceuticals, Inc. shares (Form 4)
Traded May 14, 2026 · Filed May 14, 2026
On May 14, 2026, DeLong Mark Jeffrey (Chief Business & Strat Officer) disposed of 149,937 Apellis Pharmaceuticals, Inc. shares, leaving 0 shares. Filed May 14, 2026 (Form 4).
- Disposed of
- 149,937 shares
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Chief Business & Strat Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Other | 114,591 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 41,250 | 41,250 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 41,250 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 19,006 | 19,006 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 19,006 | 0 | Direct | |
| May 14, 2026 | Common Stock | Award | 36,606 | 36,606 | Direct | |
| May 14, 2026 | Common Stock | Award | 18,303 | 18,303 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 18,303 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 36,606 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 4,909 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 8,482 | 0 | Direct | |
| May 14, 2026 | Common Stock | Disposition | 21,381 | 0 | Direct |
Source
Related
- Apellis Pharmaceuticals, Inc.
- DeLong Mark Jeffrey
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026